Amy Hannaford

Amy Hannaford is a seasoned professional in the life sciences sector, currently serving as a Life Sciences Senior Manager at Wavestone since January 2021. In this role, Amy has contributed to the development of Clinical Trial Diversity and Health Equity strategies for global pharmaceutical organizations, including assessments, capability building, and identifying best practices. Amy's expertise encompasses patient-centered development within research and development and has led initiatives to improve commercial patient experience through data and insights. Previously, Amy held various roles at Accenture, focusing on process improvement, strategy, and innovation within clinical trial operations. Amy holds a BSc in Neuroscience from the University of Leeds, obtained in 2016, and completed studies at Dauntsey's School from 2006 to 2013.